American Well (AMWL) Projected to Release Quarterly Earnings on Tuesday

Posted by George Bondi on Jul 28th, 2026

American Well (NYSE:AMWL – Get Free Report) is expected to release its Q2 2026 results after the market closes on Tuesday, August 4th. Analysts expect American Well to announce earnings of ($0.60) per share and revenue of $49.8780 million for the quarter. Investors can check the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Tuesday, August 4, 2026 at 5:00 PM ET.

American Well (NYSE:AMWL – Get Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The company reported ($0.66) EPS for the quarter, topping analysts’ consensus estimates of ($0.77) by $0.11. The business had revenue of $54.88 million during the quarter, compared to analysts’ expectations of $51.54 million. American Well had a negative return on equity of 32.11% and a negative net margin of 37.02%. On average, analysts expect American Well to post $-3 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

American Well Price Performance

NYSE AMWL traded down $0.24 during trading on Tuesday, reaching $10.81. 10,069 shares of the company’s stock were exchanged, compared to its average volume of 96,037. The business has a 50 day moving average price of $9.36 and a 200-day moving average price of $6.91. The stock has a market capitalization of $178.93 million, a P/E ratio of -1.99 and a beta of 1.69. American Well has a fifty-two week low of $3.71 and a fifty-two week high of $13.45.

Insider Activity

In related news, insider Phyllis Gotlib sold 6,677 shares of American Well stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $9.33, for a total transaction of $62,296.41. Following the completion of the sale, the insider directly owned 152,754 shares of the company’s stock, valued at approximately $1,425,194.82. This trade represents a 4.19% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Stephen J. Schlegel sold 9,750 shares of the business’s stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $8.76, for a total value of $85,410.00. Following the completion of the sale, the director owned 54,553 shares of the company’s stock, valued at $477,884.28. This trade represents a 15.16% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 29,225 shares of company stock valued at $268,623. 12.84% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in AMWL. Vanguard Group Inc. lifted its holdings in shares of American Well by 2.5% during the third quarter. Vanguard Group Inc. now owns 650,102 shares of the company’s stock worth $3,998,000 after buying an additional 15,797 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of American Well by 2.3% in the fourth quarter. Geode Capital Management LLC now owns 152,742 shares of the company’s stock valued at $750,000 after acquiring an additional 3,450 shares during the period. Squarepoint Ops LLC grew its stake in shares of American Well by 74.5% in the fourth quarter. Squarepoint Ops LLC now owns 115,061 shares of the company’s stock valued at $565,000 after acquiring an additional 49,135 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of American Well by 36.0% in the third quarter. Dimensional Fund Advisors LP now owns 97,382 shares of the company’s stock valued at $599,000 after acquiring an additional 25,798 shares in the last quarter. Finally, Marshall Wace LLP increased its position in American Well by 76.9% during the fourth quarter. Marshall Wace LLP now owns 87,447 shares of the company’s stock worth $429,000 after acquiring an additional 38,018 shares during the period. Institutional investors own 56.05% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently commented on AMWL shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of American Well in a research note on Friday, July 17th. Truist Financial set a $7.50 price target on American Well in a report on Monday, June 8th. Wells Fargo & Company lifted their price objective on shares of American Well from $9.00 to $16.00 and gave the stock an “overweight” rating in a research report on Friday, July 17th. Morgan Stanley upped their price objective on shares of American Well from $6.00 to $6.50 and gave the company an “equal weight” rating in a report on Wednesday, May 6th. Finally, TD Cowen increased their price objective on shares of American Well from $5.00 to $8.00 and gave the company a “hold” rating in a research report on Wednesday, May 6th. One equities research analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, American Well currently has an average rating of “Hold” and a consensus target price of $8.60.

View Our Latest Stock Report on AMWL

American Well Company Profile

(Get Free Report)

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.